SUMMARY The chromosomes of a male patient who suffers from Duchenne muscular dystrophy (DMD) with a molecular deletion were examined with an improved high resolution R type replication banding technique. High resolution cytogenetic analysis of the proband revealed a deletion of the Xp2l.13 subband. His healthy mother was heterozygous for the deletion, which is subject to random X inactivation in lymphocytes. The 
SUMMARY The chromosomes of a male patient who suffers from Duchenne muscular dystrophy (DMD) with a molecular deletion were examined with an improved high resolution R type replication banding technique. High resolution cytogenetic analysis of the proband revealed a deletion of the Xp2l.13 subband. His healthy mother was heterozygous for the deletion, which is subject to random X inactivation in lymphocytes. The X chromosomes of the proband's grandmother were normal, suggesting that the deletion of the Xp2l.13 subband in the mother was a new mutation. The finding of a very small, cytologically visible Xp21.1 deletion in a male DMD patient with a molecular deletion emphasises the importance of resolving the fine structure in the Xp2l region.
Duchenne muscular dystrophy (DMD) is the most common X linked fatal disease, affecting approximately 1 in 3500 male livebirths.l Most DMD patients are sporadic cases with no previous family history of muscular dystrophy; however, theoretically, two-thirds of the patients' mothers are DMD carriers. The DMD locus was first localised to band Xp2l through the study of nmol/l-s). The patient's mother was identified as a carrier on the basis of a very raised creatine kinase activity of 8850 nmoIl-s (normal value <1250 nmol/l*s). The healthy and asymptomatic grandmother of our patient could not be identified as a carrier because of normal creatine kinase activities. analysed in detail. In this way, the interstitial Xp2l-1 deletion has been more precisely localised to subband Xp21-13 ( figs 2 and 3) .
The X chromosomes of the proband's grandmother were normal. The Xp21-1 deletion, therefore, was a new mutation in the proband's mother.
On the basis of the physical map around the DMD gene, constructed through pulsed field gel 25 29 electrophoresis, it can be calculated that the size of this DMD deletion is approximately 2000 kb. It seems probable that this deletion is smaller than all other interstitial Xp2l deletions published so far. Cytologically detectable interstitial Xp2l deletions have been observed in male patients who suffer from complex phenotypes incorporating several distinct syndromes: OTC deficiency, RP, CGD, DMD, GK deficiency, AH, and mental retardation./k2 14 15 A comparison of clinical, cytogenetic, and molecular data is given in the table. There are inconsistencies between apparently similar cytogenetic and molecular data on one hand and different clinical phenotypes of male patients on the other hand. In male patients suffering from GK deficiency and AH alone a deletion of the subband Xp212 was found,8 whereas in a few male patients with DMD, GK deficiency, and AH no X chromosome anomaly was found.7 813 Moreover, the findings of various combinations of syndromes in The identification of an inherited deletion of subband Xp21-13 in our DMD patient and in his heterozygous mother emphasises the importance of resolving the fine structure of the Xp2l region by an improved high resolution banding technique. Furthermore, improved high resolution replication banding could possibly narrow the existing gap between the resolution levels of cytogenetic and molecular techniques.
